Skip to main content

AbbVie: High Yield At A Low P/E

Over the first half of this year, pharmaceutical giant AbbVie has traded in a narrow range while meme stocks, cryptocurrencies, and other get-rich-quick schemes have diverted investor attention away from more conventional equities.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.